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Cocaine-Induced Hepatonephrotoxicity: A Case Report 
GuiUermo P. Gubbins, MD,* Rhett M. Schiffman, MD,* Ravindra S. Alapati, MD,* 
and Surinder K. Batra, MD* 
Hepatotoxiciry due to cocaine has been weU described in animal models. There are few reports on 
cocaine-induced hepatic injury in humans; however, its link to rhabdomyolysis and renal failure is 
better known. We report a case of reversible acute hepatonephrotoxicity associated with recreational 
cocaine use. The proposed mechanisms responsible for its hepatic and renal toxicity are reviewed. 
(Henry Ford Hosp MedJ 1990;38:55-6) 
Cocaine, an alkaloid prepared from the leaves of Erythroxyton coca, is recognized as one of the most dangerous if i ici t 
dmgs in common use today. As cocaine abuse has escalated, co-
caine-related emergency room visits, hospital admissions, car-
diovascular events, and deaths due to overdosage have increased 
throughout the nation (1). Cocaine-mediated hepatotoxicity in 
humans has been suspected since 1967 (2). Since then, numer-
ous studies in mice have defined several possibte mechanisms of 
liver injury (3,4). Cases of probable cocaine-induced liver disor-
ders in humans have been reported only recentiy (4,5), and co-
caine-induced nephrotoxicity has been reported with increasing 
frequency during the last two years (6-11). We report a case of 
acute, reversible hepatonephrotoxicity associated with recre-
ational cocaine use. 
Case Report 
A previously healthy 35-year-old woman came to the emergency 
room complaining of myalgias, fever, chills, diffuse abdominal pain, 
diarthea, and vomiting. The symptoms had begun four days after drink-
ing alcohol and smoking "crack" cocaine. She also related passing dark 
urine two days prior to admission. The patient denied intravenous dmg 
use, had no history of hepatitis, and had one sexual partner who did not 
use drugs intravenously. She worked as a janitor in a nursing home, but 
was not aware of recent exposure to organic solvents. She did admit to 
drinking one-half pint of vodka or whiskey two to three times a week. 
On admission the patient's blood pressure was normal but her pulse 
was 120 beats/min and her temperature was 37.6°C (99.7°F). Jaundice 
was present along with mild hepatomegaly and tenderness in the right 
upper quadrant. The complete blood count was normal, but the 
creatinine was 468 ixmol/L (5.3 mg/dL), and blood urea nifi-ogen 8.6 
mmol/L (24 mg/dL). The prothrombin time was 20.5 seconds (control 
10.5 seconds) and the partial thromboplastin time was 38 seconds (nor-
mal 22 to 36 seconds). The bilirubin was 51 |xmol/L (3.0 mg/dL [2.5 
mg/dL direct]), SGOT 1,711 lU/L (normal < 33 lU/L), SGPT 9,295 IU/ 
L (normal < 40 lU/L), alkaline phosphatase 131 lU/L (normal 0 to 100 
lU/L), and creatine phosphokinase 258 lU/L (normal 0 to 190 lU/L). 
Ethanol was not detected in the serum. Urinalysis revealed 14-
"blood," 24- bilirubin, and 3 4- albumin. Eight red blood cells, 4 to 6 
renal tubular cells in clumps, 0 to 1 hyaline casts, and 3 to 4 granular 
casts were seen per high power field. Urinary myoglobin was not as-
sayed, but urinary sodium was 38 mEq/L and the fractional sodium ex-
cretion was 1.6%. The urine drug screen was positive for cocaine me-
tabolites, morphine, codeine, and amphetamines. Serologic tests for 
hepatitis A and B were negative. 
The patient was given supportive care. The SGOT peaked at 2,482 
lU/L on the second day but administration of vitamin K quickly cor-
rected her coagulopathy. The serum creatinine peaked at 1,547 ixmol/L 
(17.5 g/dL) on the eighth day; however, she maintained a urine output 
ranging from 1,600 to 2,400 mL/24 hrs. The patient did not require di-
alysis and was discharged after 15 days with a seram creatinine of 371 
|i.mol/L (4.2 mg/dL) and an SGOT of 28 lU/L. 
Discussion 
tn the mouse, cocaine is largely detoxified by plasma and 
liver chotinesterases to the water-soluble, nontoxic metabolites 
benzoyl ecgonine and ecgonine methyl ester which are excreted 
in the urine. However, a minor oxidative pathway, centered 
around the tropane nitrogen, is believed to be responsible for the 
generation of hepatotoxic metabolites (1,3,4). Two mechanisms 
have been proposed to account for the production of these hepa-
totoxic metabolites in man. The first of these involves a futile, 
enzymatically catalyzed cycling between N-hydroxy norco-
caine and norcocaine nitroxide, which depletes intracellular 
NADPH, thereby reducing intrahepatic glutathione. As a conse-
quence, cellular concentrations of hydrogen peroxide and super-
oxide radicals, which are generated by normal cellular metabo-
fism, reach toxic levels resulting in lipid peroxidation ofthe 
cellular membranes and cell wall dismption (3). The second pro-
posed mechanism is based on the further oxidation of norco-
caine nitroxide to the extremely reactive nitrosonium ion which 
also depletes glutathione. Catecholamines, whose circulating 
Submitted for publication: December?. 1989. 
Accepled for publication: January 23, 1990. 
'Division of Gastroenterology, Henry Ford Hospital. 
tBone and Mineral Division, Henry Ford Hospilal. 
tFormeriy Division of Gastroenterology, Henry Ford Hospilal. Curtently Anaheim Fam-
ily Practice, Anaheim, CA. 
Address cortespondence to Dr Batra. Division of Gastroenterology. Henry Ford Hospi-
tal. 2799 W Grand Blvd, Detroit, Ml 48202. 
Henry Ford Hosp Med J—Vol 38, No I , 1990 Cocaine-induced Hepatonephrotoxicity—Gubbins et al 55 
levels are elevated as a consequence of cocaine use, may con-
tribute by causing liver damage directly or by serving as cofac-
tors for the oxidation of norcocaine nitroxide to the nitrosonium 
ion (4). 
It has been suggested that individuals with low plasma 
pseudocholinesterase activity could be especially susceptible to 
the hepatotoxicity of cocaine because more cocaine may be 
shunted through the oxidative bioactivation pathway. Similarly, 
individuals deficient in gIucose-6-phosphate dehydrogenase 
would have an increased risk for cocaine-induced hepatotoxicity 
because they generate fewer reducing equivalents (NADPH) 
than do normal individuals (3). Finally, cytochrome P^ o^ oxidase 
system inducers, such as ethanol and phenobarbital, which po-
tentiate cocaine-induced hepatotoxicity in mice, could play a 
similar predisposing role in human subjects. 
The only report of subclinical cocaine hepatotoxicity ap-
peared in 1967 (2). Of the 89 heroin users evaluated at a psychi-
atric institution, most of whom were also users of cocaine, six 
were jaundiced and 80% of the patients had serum enzyme ab-
normalities which returned to normal after abstinence. How-
ever, the contribution of cocaine to hepatotoxicity could not be 
dissociated from that of heroin; and viral hepatitis, which is 
prevalent among intravenous drug users, was not excluded 
serologically. Considering the large number of people who 
abuse cocaine, it is surprising that cases of overt hepatotoxicity 
are so rare (4-6); however, the susceptibility to liver damage 
from cocaine is influenced by so many different factors that 
frank hepatotoxicity may not become a common feature of co-
caine addiction (4). It is possible that ethanol, by inducing 
cytochrome P45„, predisposed our patient to cocaine hepatotox-
icity. Glucose-6-phosphate dehydrogenase and plasma 
pseudocholinesterase levels were not measured. 
Cocaine abuse has been linked recently to rhabdomyolysis 
and acute renal failure (6-11), The mechanisms for this are not 
completely understood; however, the dmg is known to cause hy-
perpyrexia by affecting the temperature-regulating center in the 
hypothalamus (1) and can also induce seizures and hyperac-
tivity. Each of these factors may contribute to cocaine-induced 
rhabdomyolysis (1). The renal failure associated with cocaine 
abuse and rhabdomyolysis is usually nonoliguric, self-limited, 
and seldom requires dialysis (6). Factors other than myoglobin, 
however, may contribute to the development of acute renal 
failure in cocaine intoxication and may alter the course of the 
kidney failure. These include hypotension, hypovolemia, and 
disseminated intravascular coagulation (6). In addition, cocaine 
may have a direct vasoconstrictive effect on the renal vas-
culature, and a case of renal infarction associated with intra-
venous cocaine use has been reported (12). 
Our patient's urinalysis, fractional sodium excretion, and 
clinical course were most consistent with nonoliguric acute tu-
bular necrosis. Consequently, although we cannot mie out a di-
rect tubular cocaine toxicity, we feel that our patient's renal 
failure was probably due to rhabdomyolysis, in view ofthe his-
tory of passing dark urine (possibly myoglobin) two days before 
admission. 
White hepatonephrotoxicity is probably a rare complication 
of cocaine abuse, it should be considered in the differential diag-
nosis of patients with simultaneous hepatic and renal failure, es-
pecially in the presence of potentially predisposing factors such 
as ethanol and barbiturate abuse or gIucose-6-phosphate de-
hydrogenase and p.seudochoIinesterase deficiencies. 
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